4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-004076
Chair and CEO sold 25,580 shares at an average $77.94 ($1,993,731)
- Chair and CEO acquired 25,580 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lewis William Chair and CEO | 2025-02-03 | Option exercise 10b5-1 | +18,750 | $22.76 | $426,750 | 398,284 | D: show line 1 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −241 | $75.25 | $18,135 | 398,043 | D: show line 2 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −1,872 | $76.35 | $142,927 | 396,171 | D: show line 3 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −9,869 | $77.97 | $769,486 | 386,302 | D: show line 4 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −6,768 | $78.44 | $530,882 | 379,534 | D: show line 5 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Option exercise 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I: show line 6 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −41 | $74.86 | $3,069 | 240,713 | I: show line 7 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −745 | $76.43 | $56,940 | 239,968 | I: show line 8 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −3,463 | $77.95 | $269,941 | 236,505 | I: show line 9 in the form |
| Lewis William Chair and CEO | 2025-02-03 | Sale 10b5-1 | −2,581 | $78.40 | $202,350 | 233,924 | I: show line 10 in the form |
| Open-market sales · 25,580 sh · avg $77.94 · $1,993,731 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lewis William Chair and CEO | 2025-02-03 | Option exercise · Stock Option (right to buy) 10b5-1 | −18,750 | 56,250 | D: show line 11 in the form | |||||
| Lewis William Chair and CEO | 2025-02-03 | Option exercise · Stock Option (right to buy) 10b5-1 | −6,830 | 211,800 | I: show line 12 in the form |
Loading xslF345X05/wk-form4_1738791860.xml…